Annals of Colorectal Research

Published by: Kowsar

Why Colorectal Diseases are Important?

Kamran Bagheri Lankarani ORCID 1 , *
Author Information
1 Health policy research center , Shiraz University of medical sciences
Article information
  • Annals of Colorectal Research: June 01, 2013, 1 (1); 1-2
  • Published Online: June 30, 2013
  • Article Type: Editorial
  • Received: April 5, 2013
  • Accepted: April 9, 2013
  • DOI: 10.17795/acr-11480

To Cite: Bagheri Lankarani K. Why Colorectal Diseases are Important?, Ann Colorectal Res. 2013 ; 1(1):1-2. doi: 10.17795/acr-11480.

Copyright © 2013, Colorectal Research Center and Health Policy Research Center of Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012; 380(9856): 1840-50
  • 2. Pourhoseingholi MA. Increased burden of colorectal cancer in Asia. World J Gastrointest Oncol. 2012; 4(4): 68-70[DOI][PubMed]
  • 3. Masoompour Seyed Masoom, Yarmohammadi Hooman, Rezaianzadeh Abbas, Lankarani Kamran Bagheri. Cancer incidence in southern Iran, 1998–2002: Results of population-based cancer registry. Cancer epidemiology. 2011; 35(5)
  • 4. Torres Udos S, Almeida TE, Netinho JG. Increasing hospital admission rates and economic burden for colorectal cancer in Brazil, 1996-2008. Rev Panam Salud Publica. 2010; 28(4): 244-8[PubMed]
  • 5. Beaulieu N, Bloom D, Bloom R, Stein R. Breakaway: The global burden of cancer—challenges and opportunities. The Economist Intelligence Unit. 2009;
  • 6. Dunne C, Harewood GC. Hidden extras: the projected impact of colorectal cancer screening and the burden of procedures on screening centers. Gastrointest Endosc. 2011; 74(2): 448-9[DOI][PubMed]
  • 7. Shellnut JK, Wasvary HJ, Grodsky MB, Boura JA, Priest SG. Evaluating the age distribution of patients with colorectal cancer: are the United States Preventative Services Task Force guidelines for colorectal cancer screening appropriate? Dis Colon Rectum. 2010; 53(1): 5-8[DOI][PubMed]
  • 8. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006; 240(1): 143-7
  • 9. Ray S, Bonthapally V, Holen KD, Gauthier G, Wu EQ, Cloutier M, et al. Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors. J Med Econ. 2013; 16(2): 221-30[DOI][PubMed]
  • 10. Burudpakdee C, Zhao Z, Munakata J, Gao S, Trochlil K, Barber B. Economic burden of toxicities associated with metastatic colorectal cancer treatment regimens containing monoclonal antibodies. J Med Econ. 2012; 15(2): 371-7[DOI][PubMed]
  • 11. Reuland DS, Pignone MP. Addressing disparities in colorectal cancer burden: how far could equal health care access bring us? Cancer Epidemiol Biomarkers Prev. 2012; 21(5): 707-8[DOI][PubMed]
  • 12. Shieh SC, Tung HS, Liang SY. Social support as influencing primary family caregiver burden in Taiwanese patients with colorectal cancer. J Nurs Scholarsh. 2012; 44(3): 223-31[DOI][PubMed]
  • 13. Van Houtven CH, Ramsey SD, Hornbrook MC, Atienza AA, van Ryn M. Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist. 2010; 15(8): 883-93[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments